Published December 2019 | Version v1
Journal article

Research progress and clinical decision of internal mammary prophylactic radiotherapy after breast cancer surgery

  • 1. Department of Radiation Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing (China)

Description

Although the internal mammary is the lymphatic drainage site for breast cancer, whether postoperative radiotherapy needs to be irradiated remains controversial. In recent years, several random studies have discussed internal mammary radiotherapy to varying degrees and no evidence has obtained that internal mammary radiotherapy bring clinical benefits to overall survival. In clinical practice, internal mammary prophylactic radiotherapy should maintain the balance among the risk of tumor recurrence, prescription dose and radiotherapy techniques to avoid the increased risk of radiotherapy-related death that offsets the possible survival benefits. (authors)

Additional details

Publishing Information

Journal Title
Chinese Journal of Radiation Oncology
Journal Volume
28
Journal Issue
12
Journal Page Range
p. 949-952
ISSN
1004-4221

INIS

Country of Publication
China
Country of Input or Organization
China
INIS RN
55022301
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BALANCES; DEATH; DOSES; DRAINAGE; HAZARDS; IRRADIATION; MAMMARY GLANDS; NEOPLASMS; RADIOTHERAPY; SURGERY
Descriptors DEC
BODY; DISEASES; GLANDS; MEASURING INSTRUMENTS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY; WEIGHT INDICATORS

Optional Information

Notes
28 refs.; http://dx.doi.org/10.3760/cma.j.issn.1004-4221.2019.12.016